We are live on
!
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter
Est. Return
+19.22%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
+$294M
(+24%)
Cap. Flow
+$64.1M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
99.49%
Holding
17
New
3
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$114M |
| 2 |
PTC Therapeutics
PTCT
|
+$5.69M |
| 3 |
Quaker Houghton
KWR
|
+$225K |
| 4 |
Emergent Biosolutions
EBS
|
+$222K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$56M |
| 2 |
Precipio
PRPO
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.62% |
| 2 | Energy | 3.53% |
| 3 | Consumer Staples | 1.57% |
| 4 | Materials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Precigen
PGEN
$1.76B
| $1.15B | 74.98% |
66,993,639
+7,683,833
| +13% | +$114M |
|
|
2
Halozyme
HALO
$9.23B
| $256M | 16.64% |
14,092,771
-3,195,679
| -18% | -$56M |
|
3
Enterprise Products Partners
EPD
$82.6B
| $32.6M | 2.12% |
1,135,734
| – | – |
|
4
Alaunos Therapeutics
TCRT
$5.01M
| $31.1M | 2.02% |
64,731
| – | – |
|
5
AquaBounty Technologies
AQB
$4.99M
| $24.2M | 1.57% |
376,915
| – | – |
|
6
Energy Transfer Partners
ET
$69.9B
| $14.8M | 0.96% |
847,650
| – | – |
|
|
7
PTC Therapeutics
PTCT
$6.52B
| $6.46M | 0.42% |
+137,551
| New | +$5.69M |
|
|
NS
8
DELISTED
NuStar Energy L.P.
NS
| $4.04M | 0.26% |
145,200
| – | – |
|
|
ETP
9
DELISTED
Energy Transfer Partners, L.P.
ETP
| $3.94M | 0.26% |
176,828
| – | – |
|
|
FCSC
10
DELISTED
Fibrocell Science Inc.
FCSC
| $3.9M | 0.25% |
1,653,486
| – | – |
|
|
TCP
11
DELISTED
TC Pipelines LP
TCP
| $2.94M | 0.19% |
97,000
| – | – |
|
12
Oragenics
OGEN
$2.48M
| $1.78M | 0.12% |
860
| – | – |
|
13
Ocugen
OCGN
$460M
| $1.47M | 0.1% |
44,843
| – | – |
|
14
Theriva Biologics
TOVX
$11.1M
| $983K | 0.06% |
1,513
| – | – |
|
|
15
Quaker Houghton
KWR
$2.62B
| $261K | 0.02% |
+1,290
| New | +$225K |
|
|
16
Emergent Biosolutions
EBS
$394M
| $251K | 0.02% |
+3,810
| New | +$222K |
|
|
17
Precipio
PRPO
$44M
| $209K | 0.01% |
1,765
-2,765
| -61% | -$334K |
|
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q3 2018 Portfolio in Review
As of Q3 2018, Third Security held 17 positions worth $1.54B, up 24% from $1.25B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Third Security deployed $64.1M of net new capital in Q3 2018, opening 3 new positions and adding to 1 existing holding. Its largest new stake was PTC Therapeutics: 137,551 shares worth $6.46M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Energy and Consumer Staples.
On the sell side, the largest reduction was Halozyme, an estimated $56M trimmed.
- Third Security's largest Q3 2018 buy was PTC Therapeutics: 137,551 shares worth $6.46M.
- Third Security added most to Precigen in Q3 2018, an estimated $114M increase.
- Third Security's biggest Q3 2018 reduction was Halozyme, cutting an estimated $56M.
- Third Security's ten largest holdings make up 99% of its $1.54B portfolio in Q3 2018.
- Third Security opened 3 new positions and closed 0 in Q3 2018.
- Third Security's portfolio value rose 24% quarter-over-quarter to $1.54B.
Based on Third Security's 13F filing for Q3 2018, filed 14 Nov 2018.